Labcorp cuts growth outlook for research unit as biotech funding crunch persists
NegativeFinancial Markets

Labcorp has revised its growth outlook for its research unit, citing ongoing challenges in the biotech funding landscape. This adjustment highlights the difficulties many companies face in securing necessary investments, which could impact innovation and development in the biotech sector. As funding becomes increasingly scarce, the implications for research and advancements in healthcare could be significant.
— Curated by the World Pulse Now AI Editorial System












